on November 1, 2004
Published online before print November 1, 2004, doi: 10.1161/01.CIR.0000142866.50300.EB
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 18, 2004
From Molecular Cardiology, Department of Internal Medicine IV, University of Frankfurt, Frankfurt, Germany (I.S., J.H., C.U., A.M.Z., S.D.); the Department of Hematology, University of Tübingen, Tübingen, Germany (T.H.B.); and the Center for Cardiovascular Development, Baylor College of Medicine, Houston, Tex (H.O., M.D.S.). * To whom correspondence should be addressed. E-mail: dimmeler{at}em.uni-frankfurt.de.
Background--Cultivation of endothelial progenitor cells (EPCs) leads to premature replicative senescence, limiting ex vivo expansion for potential clinical cell therapy. Recent studies have linked senescence to the dysfunction of telomeres, the "ends" of chromosomes, via the so-called mitotic clock or culture-induced stress. The purpose of this study was to elucidate a possible role of telomere biology in the functional augmentation of EPCs by statins. Methods and Results--Human EPCs were isolated from peripheral blood. Using flow cytometry after fluorescence in situ hybridization with a telomere-specific (C3TA2)3 peptide nucleic acid probe (Flow-FISH), we found mean telomere length in untreated EPCs from healthy subjects to range between 8.5±0.2 and 11.1±0.5 kb with no change over 6 days of culture, excluding telomere erosion as one cause for premature senescence. Although mean telomere length did not differ between statin-treated and untreated EPCs, atorvastatin (0.1 µmol/L) and mevastatin (1.0 µmol/L) both led to a more than 3-fold increase in the expression of the telomere capping protein TRF2 (telomere repeat-binding factor), as shown by immunoblotting, whereas quantitative reverse transcription-polymerase chain reaction demonstrated no increase in TRF2 mRNA. Telomere dysfunction of EPCs was also paralleled by a 4-fold increase in the DNA damage checkpoint-kinase 2 (Chk2). Conversely, statin cotreatment or overexpression of TRF2 completely suppressed Chk2 induction. Finally, overexpression of a dominant negative mutant of the TRF2 protein abrogated statin-induced enhancement of migratory activity down to baseline values. Conclusions--Ex vivo culturing of EPCs leads to "uncapping" of telomeres, indicated by the loss of TRF2. Statin cotreatment of EPCs prevents impairment of their functional capacity by a TRF2-dependent, posttranscriptional mechanism. This is the first time a beneficial effect of statins on telomere biology has been described.
Revised on June 22, 2004
Accepted on June 28, 2004
Statins Enhance Migratory Capacity by Upregulation of the Telomere Repeat-Binding Factor TRF2 in Endothelial Progenitor Cells
Ioakim Spyridopoulos MD,
Key words: telomere • aging • stem cells • telomere repeat-binding factor 2
This article has been cited by other articles:
 |
|
 |
|
  I. Spyridopoulos, J. Hoffmann, A. Aicher, T. H. Brummendorf, H. W. Doerr, A. M. Zeiher, and S. Dimmeler Accelerated Telomere Shortening in Leukocyte Subpopulations of Patients With Coronary Heart Disease: Role of Cytomegalovirus Seropositivity Circulation, October 6, 2009; 120(14): 1364 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Matsumoto, V. Adams, C. Walther, C. Kleinecke, P. Brugger, A. Linke, T. Walther, F. W. Mohr, and G. Schuler Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair Eur. Heart J., February 1, 2009; 30(3): 346 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S.M. Wong, R. A. de Boer, N. J. Samani, D. J. van Veldhuisen, and P. van der Harst Telomere biology in heart failure Eur J Heart Fail, November 1, 2008; 10(11): 1049 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Spyridopoulos, S. Fichtlscherer, R. Popp, S. W. Toennes, B. Fisslthaler, T. Trepels, A. Zernecke, E. A. Liehn, C. Weber, A. M. Zeiher, et al. Caffeine Enhances Endothelial Repair by an AMPK-Dependent Mechanism Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1967 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mahmoudi, I. Gorenne, J. Mercer, N. Figg, T. Littlewood, and M. Bennett Statins Use a Novel Nijmegen Breakage Syndrome-1-Dependent Pathway to Accelerate DNA Repair in Vascular Smooth Muscle Cells Circ. Res., September 26, 2008; 103(7): 717 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Werner, M. Hanhoun, T. Widmann, A. Kazakov, A. Semenov, J. Poss, J. Bauersachs, T. Thum, M. Pfreundschuh, P. Muller, et al. Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins, Survival Pathways, and Apoptosis J. Am. Coll. Cardiol., August 5, 2008; 52(6): 470 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. van der Harst, D. J. van Veldhuisen, and N. J. Samani Expanding the Concept of Telomere Dysfunction in Cardiovascular Disease Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 807 - 808. [Full Text] [PDF]
|
|
|
|
|
|
I. Spyridopoulos, Y. Erben, T. H. Brummendorf, J. Haendeler, K. Dietz, F. Seeger, C. K. Kissel, H. Martin, J. Hoffmann, B. Assmus, et al. Telomere Gap Between Granulocytes and Lymphocytes Is a Determinant for Hematopoetic Progenitor Cell Impairment in Patients With Previous Myocardial Infarction Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 968 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S W Brouilette, A Whittaker, S E Stevens, P van der Harst, A H Goodall, and N J Samani Telomere length is shorter in healthy offspring of subjects with coronary artery disease: support for the telomere hypothesis Heart, April 1, 2008; 94(4): 422 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Wojakowski, M Kucia, M Kazmierski, M Z Ratajczak, and M Tendera Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart, January 1, 2008; 94(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.-K. Hsieh and H. I. Chen Interacting Leukocytes Predict Atherosclerosis and Restenosis Stroke, December 1, 2007; 38(12): e162 - e163. [Full Text] [PDF]
|
|
|
|
|
|
H. Oeseburg, B. D. Westenbrink, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst Can Critically Short Telomeres Cause Functional Exhaustion of Progenitor Cells in Postinfarction Heart Failure? J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1911 - 1912. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tentolouris, R. Nzietchueng, V. Cattan, G. Poitevin, P. Lacolley, A. Papazafiropoulou, D. Perrea, N. Katsilambros, and A. Benetos White Blood Cells Telomere Length Is Shorter in Males With Type 2 Diabetes and Microalbuminuria Diabetes Care, November 1, 2007; 30(11): 2909 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L.T. Ballard and J. M. Edelberg Stem Cells and the Regeneration of the Aging Cardiovascular System Circ. Res., April 27, 2007; 100(8): 1116 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Fuster and V. Andres Telomere Biology and Cardiovascular Disease Circ. Res., November 24, 2006; 99(11): 1167 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen and M. S. Goligorsky Premature senescence of endothelial cells: Methusaleh's dilemma Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1729 - H1739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sampson, M. S. Winterbone, J. C. Hughes, N. Dozio, and D. A. Hughes Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes Diabetes Care, February 1, 2006; 29(2): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Dzau, M. Gnecchi, A. S. Pachori, F. Morello, and L. G. Melo Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular Diseases Hypertension, July 1, 2005; 46(1): 7 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dong, L. E. Crawford, and P. J. Goldschmidt-Clermont Endothelial Progenitor Obsolescence and Atherosclerotic Inflammation J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1458 - 1460. [Full Text] [PDF]
|
|